Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells, after peripheral blood stem cell transplantation

Haematologica

Volumn 89, Issue 7, 2004, Pages 845-851

  Albo, Carmen ^a   De La Fuente, Javier ^a   Ares, Carmen ^a   Alonso, Carmen ^a   Feteira, Encarna ^a  

^a HOSPITAL XERAL CÍES   (Spain)

Author keywords

CD34 subsets; Immunophenotypic hematopoietic progenitor cells

Indexed keywords

CD117 ANTIBODY; CD13 ANTIBODY; CD33 ANTIBODY; CD34 ANTIBODY; CD38 ANTIBODY; CD38 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; HLA DR ANTIBODY; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL KINETICS; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLURIPOTENT STEM CELL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THROMBOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; KINETICS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 3242812918     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723-7.
2. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85:1655-8.
3. Dreger P. Allogeneic transplantation on mobilized peripheral blood progenitor cells: towards tailored cell therapy. Int J Hematol 1997;66:1-11.
4. Kwong YL, Millar JL, Powles RL. Recovery of circulating haemopoietic progenitor cells in the early phase of haemopoietic reconstitution after autologous and allogeneic bone marrow transplantation. Bone Marrow Transplant 1989;4:575-8.
5. Vannucchi AM, Bosi A, Lombardini L, Grossi A, Bacci P, Guidi S, Saccardi R, et al. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment. Exp Hematol 1995;23:1337-40.
6. Mahmut N, Katayama Y, Takenaka K, Teshima T, Ohno Y, Imajyo K, et al. Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation. Int J Hematol 1999;69:36-42.
7. Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986;67:842-5.
8. - progenitor cells. Blood 1991;77:1218-27.
9. + cells from human bone marrow, peripheral blood, and cord blood. Blood Cells 1994;20:411-23.
10. + hematopoietic progenitor cells. J Biol Regul Homeost Agents 2001;15:53-61.
11. Pavletic Z, Bishop M, Tarantolo S, Martin-Algarra S, Bierman PJ, Vose JM, et al. Hematopoietic recovery after allogeneic blood stem cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 1997;15:1608-16.
12. Olivieri A, Officlani M, Montanari M, Ciniero L, Cantori I, Ombrosi L, et al. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica 1998;83:329-37.
13. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-22.
14. Lanza F, Moretti S, Castagnari B, Montanelli F, Latorraca A, Ferrari L, et al. Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts. Haematologica 1999;84:969-77.
15. Marti GE, Stetler-Stevenson M, Bleesing JH, Fleisher A. Introduction to flow cytometry. Semin Hematol 2001;38:93-9.
16. Baech J, Johnsen HE. Technical aspects and clinical impact of hematopoietic progenitor subset quantification. Stem Cells 2000;18:76-86.
17. Mayani H, Lansdorp PM. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994;83:2410-7.
18. Tollerud DJ, Brown LM, Clark JW, Neuland CY, Mann DL, Pankiw-Trost LK, et al. Cryopreservation and long-term liquid nitrogen storage of peripheral blood mononuclear cells for flow cytometry analysis: effects on cell subset proportions and fluorescence intensity. J Clin Lab Anal 1991;5:255-61.
19. Ekong T, Kupek E, Hill A, Clark C, Davies A, Pinching A. Technical influences on immunophenotyping by flow cytometry. The effect of time and temperature of storage on the viability of lymphocyte subsets. J Immunol Methods 1993;164:263-73.
20. + cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. J Hematother 1994;3:253-62.
21. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994;84:2795-801.
22. Macedo A, Orfao A, Ciudad J, Gonzalez M, Vidriales B, Lopez-Berges MC, et al. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and application for the detection of minimal residual disease. Leukemia 1995;9:1896-901.
23. Lowenthal RM, Faberes C, Marit G, Boiron JM, Cony-Makhoul P, Pigneux A, et al. Factors influencing haematopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience. Bone Marrow Transplant 1998;22:763-70.
24. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-9.